UCB, a global biopharmaceutical company, announced that the Journal of Neurology has published data from the Phase 3 RAISE study and the ongoing RAISE-XT open-label extension (OLE) study on the long-term effects of zilucoplan on fatigue in adult patients with…
Sanofi, the largest private contributor to France’s health ecosystem security and independence, announced a €1 billion investment to expand bioproduction at its sites in Vitry-sur-Seine, Le Trait, and Lyon Gerland. This initiative will create over 500 jobs, enhancing France’s capacity…
AbbVie (NYSE: ABBV) and Gilgamesh Pharmaceuticals have announced a collaboration and option-to-license agreement aimed at developing next-generation therapies for psychiatric disorders. This partnership combines AbbVie’s psychiatric expertise with Gilgamesh’s innovative research platform to discover novel neuroplastogens. Classic psychedelic compounds offer…
The anticipated growth of the global PEGylated proteins market is significant, with projections indicating a rise from $10.2 billion in 2023 to $15.9 billion by 2028, reflecting a robust compound annual growth rate (CAGR) of 9.4% over the forecast period.…
A clinical-stage biopharmaceutical company, specializing in the advancement and market introduction of seralutinib for the management of pulmonary arterial hypertension (PAH) and pulmonary hypertension linked to interstitial lung disease (PH-ILD), has announced the approval of an inducement grant. The Compensation…
A leading performance beauty enterprise, specializing in curating an aesthetic range of consumer brands, has announced the allocation of non-qualified stock options for the acquisition of a combined total of 10,990 shares of Evolus, alongside 42,759 restricted stock units (RSUs)…
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) revealed today its plans to showcase pivotal findings from the CAHtalyst™ Adult Phase 3 clinical study, shedding light on baseline characteristics of adults grappling with congenital adrenal hyperplasia (CAH). Additionally, the presentation encompassed insights gleaned…
CVS Health® Survey Highlights Growing Mental Health Concerns A recent survey conducted by CVS Health® (NYSE: CVS) in collaboration with Morning Consult reveals an alarming trend: concerns about mental health are on the rise across the United States. Key findings…
Sanofi, in its pursuit of a robust vaccine portfolio, has forged a co-exclusive licensing agreement with Novavax, a biotech firm headquartered in Maryland, USA. The terms of this agreement encompass several key elements: Sanofi gains a co-exclusive license to globally…
Total knee replacement surgery is a prevalent procedure, with approximately 790,000 surgeries performed annually in the U.S. This number is expected to rise due to factors like an aging population, increasing rates of obesity, and a growing number of younger…
Shionogi, in collaboration with Nagasaki University (Administrative Office: Nagasaki; President: Takeshi Nagayasu, M.D., Ph.D.), the National Institute of Infectious Diseases (Head Office: Shinjuku-ku, Tokyo; Director: Takashi Wakita), and the non-profit research and development organization Medicines for Malaria Venture (MMV), has…
Kindeva Drug Delivery, a prominent figure in the realm of drug-device combination products, has unveiled its plans to bolster its manufacturing capabilities with a second production line for pressurized metered-dose inhaler (pMDI) products at its facility in Loughborough, U.K. This…
